[1]
“Predictor Response of Monotherapy with Methotrexate with Triple DMARDS Therapy in Patients of Rheumatoid Arthritis”, L&S, vol. 6, no. 1, p. 07, Jan. 2025, doi: 10.37185/LnS.1.1.501.